Cyclosporin a enhances the apoptotic effects of N-(4-hydroxyphenyl)retinamide in breast cancer cells

International Journal of Cancer

Volumn 101, Issue 3, 2002, Pages 243-247

  Lim, Soo Jeong ^a,b   Simeone, Ann Marie ^a   Kim, Chong Kook ^c   Tari, Ana M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b National Cancer Center   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Apoptosis; Breast cancer; Cyclosporin A; N (4 hydroxyphenyl)retinamide; Nitric oxide

Indexed keywords

CYCLOSPORIN A; ESTROGEN RECEPTOR; FENRETINIDE; FREE RADICAL; NITRIC OXIDE;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CELL LINE; CELL STRAIN MCF 7; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; CELL DIVISION; CYCLOSPORINE; DRUG SYNERGISM; FEMALE; FENRETINIDE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; NITRIC OXIDE; RECEPTORS, ESTROGEN; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0037144353     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10596     Document Type: Article

References (33)

1. Retinoids in cancer chemoprevention
2. Chemoprevention of breast cancer with fenretinide
3. Pharmacokinetics of N-(4-hydroxyphenyl)-all-trans retinamide in rats
4. N-(4-Hydroxyphenyl) retinamide. A new retinoid for prevention of breast cancer in rat
5. N-Nitrosodiethylamine-induced nodule-like alveolar lesion and its prevention by a retinoid in BALB/c mouse mammary glands in the whole organ in culture
6. Therapeutic effect of N-(4-hydroxyphenyl) retinamide on N-methyl-N-nitrosourea-induced rat mammary cancer
7. Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats
8. Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer
9. Chemoprevention of breast cancer: The Italian experience
10. Phase II study of fenretinide (N-[4-hydroxyphenyl]retinamide) in advanced breast cancer and melanoma
11. Tamoxifen and fenretinide in women with metastatic breast cancer
12. Combined effect of tamoxifen or interferon-β and 4-hydroxyphenylretinamide on the growth of breast cancer cell lines
13. Synergistic antitumor effects of a combination of interferon and tamoxifen on estrogen receptor-positive and receptor-negative human tumor cell lines in vivo and in vitro
14. Fenretinide and its relation to cancer
15. Nitric oxide-induced cytostasis and cell cycle arrest of a human breast cancer cell line (MDA-MB-231): Potential role of cyclin D1
16. Potentiation of nitric oxide-induced apoptosis of MDA-MB-468 cells by farnesyltransferase inhibitor: Implications in breast cancer
17. Nitric oxide-mediated apoptosis in human breast cancer cells requires changes in mitochondrial functions and is independent of CD95 (APO-1/Fas)
18. Relaxin activates the L-arginine-nitric oxide pathway in human breast cancer cells
19. ZR-75-1 human breast cancer cells: Expression of inducible nitric oxide synthase and effect of tamoxifen and phorbol ester on nitric oxide production
20. Induction of inducible nitric oxide synthase is an essential part of tumor necrosis factor-alpha-induced apoptosis in MCF-7 and other epithelial tumor cells
21. Differential effects of retinoids on nitric oxide production by promonocytic U937 cells and ZR-75-1 human breast cancer cells
22. Mitochondrial permeability transition is a central coordinating event in N-(4-hydroxyphenyl)retinamide-induced apoptosis
23. Implication of mitochondria-derived reactive oxygen species, cytochrome c and caspase-3 in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells
24. Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells
25. Antioxidant properties of N-(4-hydroxyphenyl)retinamide (fenretinide)
26. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphehyl)-retinamide in neuroblastoma cell lines
27. Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl-)retinamide and modulators of ceramide metabolism
28. Mediation of N-(4-hydroxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanisms
29. Induction of apoptosis by N-(4-hydroxyphenyl)retinamide and its association with reactive oxygen species, nuclear retinoic acid receptors, and apoptosis-related genes in human prostate carcinoma cells
30. Mitochondrial respiration is uniquely associated with the prooxidant and apoptotic effects of N-(4-hydroxyphenyl)retinamide
31. Long-term effects of fenretinide, a retinoic acid derivative, on the insulin-like growth factor system in women with early breast cancer
32. Suppression of cell proliferation and telomerase activity in 4-(hydroxyphenyl)retinamide-treated mammary tumors
33. N-(4-Hydroxyphenyl)retinamide activation of transforming growth factor-beta and induction of apoptosis in human breast cancer cells